• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An integrative model for recurrence in ovarian cancer.

作者信息

Laios Alexandros, O'Toole Sharon A, Flavin Richard, Martin Cara, Ring Martina, Gleeson Noreen, D'Arcy Tom, McGuinness Eamonn P J, Sheils Orla, Sheppard Brian L, O' Leary John J

机构信息

Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St, James's Hospital, Dublin 8, Ireland.

出版信息

Mol Cancer. 2008 Jan 22;7:8. doi: 10.1186/1476-4598-7-8.

DOI:10.1186/1476-4598-7-8
PMID:18211683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2248209/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/f88f01849198/1476-4598-7-8-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/44ff0e7c33c5/1476-4598-7-8-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/683b484702b2/1476-4598-7-8-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/02d73eba03e0/1476-4598-7-8-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/5cd6a1a862d1/1476-4598-7-8-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/49e5b7604efe/1476-4598-7-8-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/fc97c967cc59/1476-4598-7-8-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/8487341c2dd7/1476-4598-7-8-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/50bc6f9c1e21/1476-4598-7-8-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/f88f01849198/1476-4598-7-8-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/44ff0e7c33c5/1476-4598-7-8-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/683b484702b2/1476-4598-7-8-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/02d73eba03e0/1476-4598-7-8-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/5cd6a1a862d1/1476-4598-7-8-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/49e5b7604efe/1476-4598-7-8-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/fc97c967cc59/1476-4598-7-8-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/8487341c2dd7/1476-4598-7-8-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/50bc6f9c1e21/1476-4598-7-8-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a5e/2248209/f88f01849198/1476-4598-7-8-9.jpg

相似文献

1
An integrative model for recurrence in ovarian cancer.卵巢癌复发的综合模型。
Mol Cancer. 2008 Jan 22;7:8. doi: 10.1186/1476-4598-7-8.
2
Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.上皮性卵巢肿瘤的基因表达谱与恶性潜能相关。
Mol Cancer. 2004 Oct 7;3:27. doi: 10.1186/1476-4598-3-27.
3
Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles.
Clin Cancer Res. 2005 Nov 1;11(21):7958-9; author reply 7959. doi: 10.1158/1078-0432.CCR-05-1216.
4
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.miR-9和miR-223在复发性卵巢癌中的潜在作用。
Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35.
5
Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.上皮性卵巢癌的遗传和临床异质性建模。
Carcinogenesis. 2011 Oct;32(10):1540-9. doi: 10.1093/carcin/bgr140. Epub 2011 Aug 22.
6
miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.miR-145 通过靶向高迁移率族蛋白 A2 对卵巢癌患者的预后具有较强的预测作用。
Cancer Lett. 2015 Jan 28;356(2 Pt B):937-45. doi: 10.1016/j.canlet.2014.11.011. Epub 2014 Nov 10.
7
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.基因表达谱可预测卵巢癌患者在铂类-紫杉醇化疗后的早期复发。
Clin Cancer Res. 2005 Mar 15;11(6):2149-55. doi: 10.1158/1078-0432.CCR-04-1673.
8
Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin?基因表达谱分析揭示了母鸡卵巢癌中差异表达的基因：支持输卵管起源？
Horm Cancer. 2010 Aug;1(4):177-86. doi: 10.1007/s12672-010-0024-8.
9
Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.卵巢颗粒细胞瘤中PTEN和P13K亚基基因的表达状态及突变分析
Int J Gynecol Cancer. 2009 Apr;19(3):339-42. doi: 10.1111/IGC.0b013e3181a1cdfd.
10
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.microRNA-187 通过靶向Disabled 同源物-2 调控卵巢癌进展。
Oncogene. 2012 Feb 9;31(6):764-75. doi: 10.1038/onc.2011.269. Epub 2011 Jul 4.

引用本文的文献

1
Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.卵巢癌免疫相关基因标志物的预后、治疗和诊断价值。
Cancer Control. 2023 Jan-Dec;30:10732748231168756. doi: 10.1177/10732748231168756.
2
Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.白细胞介素-1 系统的负调控：白细胞介素-1R2 和白细胞介素-1R8 的作用及其在病理生理学和疾病中的相关性。
Front Immunol. 2022 Feb 8;13:804641. doi: 10.3389/fimmu.2022.804641. eCollection 2022.
3
IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability.

本文引用的文献

1
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.膀胱及其他癌症中异常的成纤维细胞生长因子受体信号传导
Differentiation. 2007 Nov;75(9):831-42. doi: 10.1111/j.1432-0436.2007.00210.x. Epub 2007 Aug 14.
2
Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad.锌指基因217（ZNF217）扩增与癌症：当好“手指”变坏时
Biochim Biophys Acta. 2007 Jun;1775(2):333-40. doi: 10.1016/j.bbcan.2007.05.001. Epub 2007 May 22.
3
PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
白细胞介素1受体2阻断通过损害泛素特异性蛋白酶15依赖的BMI1稳定性抑制乳腺肿瘤发生和进展。
Adv Sci (Weinh). 2019 Nov 13;7(1):1901728. doi: 10.1002/advs.201901728. eCollection 2020 Jan.
4
Association between IL-1R2 polymorphisms and lung cancer risk in the Chinese Han population: A case-control study.白细胞介素-1受体2基因多态性与中国汉族人群肺癌风险的关联：一项病例对照研究。
Mol Genet Genomic Med. 2019 May;7(5):e644. doi: 10.1002/mgg3.644. Epub 2019 Mar 20.
5
Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.通过负向调节因子 IL-1R2 和 IL-1R8 来调节炎症和免疫。
Immunol Rev. 2018 Jan;281(1):233-247. doi: 10.1111/imr.12609.
6
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.细胞因子诱饵受体和清道夫受体作为免疫和炎症的关键调节因子。
Cytokine. 2016 Nov;87:37-45. doi: 10.1016/j.cyto.2016.06.023. Epub 2016 Aug 4.
7
Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.靶向AMPK信号通路对抗卵巢癌：机遇与挑战
Acta Biochim Biophys Sin (Shanghai). 2016 Apr;48(4):301-17. doi: 10.1093/abbs/gmv128. Epub 2016 Jan 12.
8
Entropic analysis reveals a connection between the recurrence of cancer and chemotherapy.熵分析揭示了癌症复发与化疗之间的联系。
Saudi J Biol Sci. 2015 Nov;22(6):674-8. doi: 10.1016/j.sjbs.2015.05.005. Epub 2015 May 13.
9
Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.苦瓜（苦瓜属）提取物通过靶向AMPK信号级联抑制卵巢癌细胞的致瘤性并克服顺铂耐药性。
Integr Cancer Ther. 2016 Sep;15(3):376-89. doi: 10.1177/1534735415611747. Epub 2015 Oct 19.
10
The double face of Morgana in tumorigenesis.莫尔加娜在肿瘤发生中的双面性。
Oncotarget. 2015 Dec 15;6(40):42603-12. doi: 10.18632/oncotarget.6058.
PEA3对于表皮生长因子受体刺激的基质金属蛋白酶的最佳表达以及卵巢肿瘤细胞的侵袭是必需的。
Mol Cancer Res. 2007 May;5(5):413-21. doi: 10.1158/1541-7786.MCR-07-0019. Epub 2007 May 2.
4
Genetic determinants of cancer metastasis.癌症转移的遗传决定因素。
Nat Rev Genet. 2007 May;8(5):341-52. doi: 10.1038/nrg2101.
5
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.血管重塑的介质被用于肺转移的连续步骤。
Nature. 2007 Apr 12;446(7137):765-70. doi: 10.1038/nature05760.
6
Prostaglandin E2 induces the expression of IL-1alpha in colon cancer cells.前列腺素E2诱导结肠癌细胞中白细胞介素-1α的表达。
J Immunol. 2007 Apr 1;178(7):4097-103. doi: 10.4049/jimmunol.178.7.4097.
7
Patterns of somatic mutation in human cancer genomes.人类癌症基因组中的体细胞突变模式。
Nature. 2007 Mar 8;446(7132):153-8. doi: 10.1038/nature05610.
8
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.间充质-上皮转化促进膀胱癌转移：成纤维细胞生长因子受体2的作用
Cancer Res. 2006 Dec 1;66(23):11271-8. doi: 10.1158/0008-5472.CAN-06-2044.
9
Genomic signatures to guide the use of chemotherapeutics.指导化疗药物使用的基因组特征。
Nat Med. 2006 Nov;12(11):1294-300. doi: 10.1038/nm1491. Epub 2006 Oct 22.
10
Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?
Gynecol Oncol. 2007 Feb;104(2):345-51. doi: 10.1016/j.ygyno.2006.08.039. Epub 2006 Oct 5.